Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq:
DH), an industry leader in healthcare commercial intelligence,
today announced the closing of its previously announced initial
public offering of 17,888,888 shares of its Class A common stock,
which includes the full exercise by the underwriters of their
option to purchase up to an additional 2,333,333 shares of its
Class A common stock, at a public offering price of $27.00 per
share. Aggregate gross proceeds to Definitive Healthcare were
approximately $483 million, before underwriting discounts,
commissions, and estimated offering expenses. Definitive
Healthcare’s Class A common stock began trading on the Nasdaq
Global Select Market under the ticker symbol “DH” on September 15,
2021.
Goldman Sachs & Co. LLC and J.P. Morgan acted as lead joint
book-running managers and representatives of the underwriters for
the proposed offering. Morgan Stanley and Barclays acted as joint
book-running managers and are also representatives of the
underwriters for the proposed offering. Credit Suisse and Deutsche
Bank Securities acted as book-runners for the proposed offering.
Canaccord Genuity, Raymond James, Stifel, Drexel Hamilton and Loop
Capital Markets acted as co-managers.
The offering was made only by means of a prospectus. A copy of
the final prospectus relating to the proposed offering may be
obtained from the SEC at www.sec.gov or from: Goldman Sachs &
Co. LLC, Attn: Prospectus Department, 200 West Street, New York, NY
10282, by telephone at (866) 471-2526 or by email at
prospectus-ny@ny.email.gs.com; J.P. Morgan Securities LLC, c/o
Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood,
NY 11717, by telephone at (866) 803-9204 or by email at
prospectuseq_fi@jpmorganchase.com; Morgan Stanley & Co. LLC,
Attn: Prospectus Department, 180 Varick Street, 2nd Floor, New
York, NY 10014, by telephone at (866) 718-1649 or by email at
prospectus@morganstanley.com; or Barclays Capital Inc., c/o
Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood,
New York 11717, by telephone at (888) 603-5847 or by at email at
barclaysprospectus@broadridge.com.
A registration statement relating to these securities was
declared effective by the Securities and Exchange Commission on
September 14, 2021. This press release shall not constitute an
offer to sell or the solicitation of an offer to buy these
securities, nor shall there be any sale of these securities in any
state or jurisdiction in which such offer, solicitation or sale
would be unlawful prior to registration or qualification under the
securities laws of any such state or jurisdiction.
About Definitive Healthcare
At Definitive Healthcare, our passion is to transform data,
analytics and expertise into healthcare commercial intelligence. We
help clients uncover the right markets, opportunities and people,
so they can shape tomorrow’s healthcare industry. Our SaaS platform
creates new paths to commercial success in the healthcare market,
so companies can identify where to go next.
Forward-Looking Statements
This Press Release contains forward-looking statements,
including, without limitation, statements concerning the conditions
of our industry and our operations, performance and financial
condition, including in particular, statements relating to our
business, growth strategies, product development efforts and future
expenses. All statements regarding Definitive Healthcare other than
statements of historical fact or relating to present facts or
current conditions included in this Press Release are
forward-looking statements. Forward-looking statements can be
identified by words such as “anticipates,” “intends,” “plans,”
“seeks,” “believes,” “estimates,” “expects” and similar references
to future periods, or by the inclusion of forecasts or projections.
Examples of forward-looking statements include, but are not limited
to, statements we make regarding the outlook for our future
business and financial performance.
Forward-looking statements in this Press Release are based on
our current expectations and assumptions regarding our business,
the economy and other future conditions. Because forward-looking
statements relate to the future, by their nature, they are subject
to inherent uncertainties, risks and changes in circumstances that
are difficult to predict. As a result, our actual results may
differ materially from those contemplated by the forward-looking
statements. Important factors that could cause actual results to
differ materially from those in the forward-looking statements
include the following: an outbreak of disease, global or localized
health pandemic or epidemic, or the fear of such an event (such as
the COVID-19 global pandemic), including the global economic
uncertainty and measures taken in response; the short- and
long-term effects of the COVID-19 global pandemic, including the
pace of recovery or any future resurgence; our ability to implement
and execute our strategic plans to transform the business; our
ability to develop or sell solutions in a timely manner or maintain
client relationships; competition for our solutions; harm to our
brand and reputation; unfavorable global economic conditions; risks
associated with operating and expanding internationally; failure to
prevent cybersecurity incidents or the perception that confidential
information is not secure; failure in the integrity of our data or
the systems; experiencing system failures and personnel
disruptions, which could delay the delivery of our solutions to our
clients; losing access to data sources; failure of our software
vendors and network and cloud providers to perform as expected or
if our relationship is terminated; loss or diminution of one or
more of our key clients, business partners or government contracts;
dependence on strategic alliances, joint ventures and acquisitions
to grow our business; our ability to protect our intellectual
property adequately or cost-effectively; claims for intellectual
property infringement; interruptions, delays or outages to
subscription or payment processing platforms; risks related to
acquiring and integrating businesses and divestitures of existing
businesses; ability to retain members of the senior leadership team
and attract and retain skilled employees and compliance with
governmental laws and regulations. Additional factors or events
that could cause our actual performance to differ from these
forward-looking statements may emerge from time to time, and it is
not possible for us to predict all of them. These factors include
but are not limited to those described under “Risk Factors” in
Definitive Healthcare’s registration statement relating to the
offering. Should one or more of these risks or uncertainties
materialize, or should any of our assumptions prove incorrect, our
actual financial condition, results of operations, future
performance and business may vary in material respects from the
performance projected in these forward-looking statements.
Any forward-looking statement made by us in this Press Release
speaks only as of the date on which it is made. Definitive
Healthcare undertakes no obligation to publicly update any
forward-looking statement, whether as a result of new information,
future developments or otherwise, except as may be required by law.
The underwriters and their affiliates (collectively, the
“Underwriters”) have not conducted any investigation with respect
to the information in this Press Release, and the Underwriters and
Definitive Healthcare expressly disclaim any and all liability for
representations, expressed or implied, contained in, or for
omissions from, this Press Release or any other written or oral
communication transmitted to any interested party in the course of
its evaluation of Definitive Healthcare. Only those particular
representations and warranties that may be made by Definitive
Healthcare in a definitive written agreement, when and if one is
executed, and subject to such limitations and restrictions as may
be specified in such agreement, shall have any legal effect.
Certain information contained in this Press Release has been
obtained from sources outside of Definitive Healthcare. While such
information is believed to be reliable for the purposes used
herein, neither Definitive Healthcare nor any of its affiliates,
directors, officers, members, employees, agents or advisors assume
any responsibility for the accuracy of such information.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210920005113/en/
Media: Danielle Johns
djohns@definitivehc.com
Sean Leous sean.leous@icrinc.com
Investor Relations: Brian
Denyeau brian.denyeau@icrinc.com
Diamond Hill Finl (MM) (NASDAQ:DHFT)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
Diamond Hill Finl (MM) (NASDAQ:DHFT)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024
